U.S. Markets close in 4 hrs 41 mins

Karuna Therapeutics, Inc. (KRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
132.50-3.11 (-2.29%)
As of 11:17AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3146.97
52 Week Low 369.58
50-Day Moving Average 3117.11
200-Day Moving Average 3112.49

Share Statistics

Avg Vol (3 month) 3145.85k
Avg Vol (10 day) 3180.98k
Shares Outstanding 529.46M
Implied Shares Outstanding 6N/A
Float 21.93M
% Held by Insiders 19.85%
% Held by Institutions 196.94%
Shares Short (Apr 29, 2021) 41.66M
Short Ratio (Apr 29, 2021) 411.61
Short % of Float (Apr 29, 2021) 47.34%
Short % of Shares Outstanding (Apr 29, 2021) 45.64%
Shares Short (prior month Mar 30, 2021) 41.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.41%
Return on Equity (ttm)-18.64%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -89.49M
Net Income Avi to Common (ttm)-90.39M
Diluted EPS (ttm)-1.90
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)571.29M
Total Cash Per Share (mrq)19.39
Total Debt (mrq)2.48M
Total Debt/Equity (mrq)0.42
Current Ratio (mrq)89.02
Book Value Per Share (mrq)6.94

Cash Flow Statement

Operating Cash Flow (ttm)-82.69M
Levered Free Cash Flow (ttm)-50.38M